Tsukuba, Japan

Katsuhiko Akiyama


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Ibaraki, JP (1999)
  • Ibaraki-ken, JP (2000)
  • Tsukuba, JP (1996 - 2011)

Company Filing History:


Years Active: 1996-2011

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Katsuhiko Akiyama: Innovator in Peptide Research

Introduction

Katsuhiko Akiyama is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of peptide research, holding a total of 6 patents. His work focuses on developing peptides with cytotoxicity inhibitory activity, which has important implications for therapeutic applications.

Latest Patents

One of Akiyama's latest patents involves a peptide having cytotoxicity inhibitory activity and a method for screening these peptides. This invention describes a peptide fragment or a series of peptide fragments containing one or more selenocysteine that exhibits lowered toxicity compared to selenocystine. The peptide fragment is characterized by an amino acid sequence from the 260th to the 362nd amino acid residues from the C-terminal of selenoprotein P. This sequence may include deletions, substitutions, or additions of one or several amino acid residues. Additionally, Akiyama has developed gene expression base sequences for therapeutic use and drugs for gene therapy.

Career Highlights

Throughout his career, Akiyama has worked with prominent organizations, including Hisamitsu Pharmaceutical Company, Inc. and the Juridical Foundation the Chemo-sero-therapeutic Research Institute. His research has contributed to advancements in the understanding and application of peptides in medicine.

Collaborations

Akiyama has collaborated with notable colleagues such as Takeshi Goto and Takashi Shimada. Their combined expertise has furthered the development of innovative solutions in peptide research.

Conclusion

Katsuhiko Akiyama's work in peptide research exemplifies the impact of innovation in the field of biotechnology. His contributions continue to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…